David J. McConkey

1987–2026 年に発表

201
論文数
40,008
被引用数
108
h 指数
196
i10 指数

被引用数

David J. McConkey の年別被引用数1945 年: 被引用 1 件1982 年: 被引用 1 件1989 年: 被引用 43 件1990 年: 被引用 75 件1991 年: 被引用 156 件1992 年: 被引用 206 件1993 年: 被引用 189 件1994 年: 被引用 152 件1995 年: 被引用 171 件1996 年: 被引用 165 件1997 年: 被引用 142 件1998 年: 被引用 175 件1999 年: 被引用 171 件2000 年: 被引用 228 件2001 年: 被引用 172 件2002 年: 被引用 230 件2003 年: 被引用 248 件2004 年: 被引用 273 件2005 年: 被引用 259 件2006 年: 被引用 250 件2007 年: 被引用 218 件2008 年: 被引用 218 件2009 年: 被引用 250 件2010 年: 被引用 271 件2011 年: 被引用 249 件2012 年: 被引用 293 件2013 年: 被引用 235 件2014 年: 被引用 290 件2015 年: 被引用 279 件2016 年: 被引用 271 件2017 年: 被引用 271 件2018 年: 被引用 319 件2019 年: 被引用 1,230 件2020 年: 被引用 1,250 件2021 年: 被引用 1,197 件2022 年: 被引用 941 件2023 年: 被引用 713 件2024 年: 被引用 1,098 件2025 年: 被引用 516 件2026 年: 被引用 17 件1946〜1981 年は被引用が無いため表示していません1983〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,239 件、この内訳の 31.4%中国: 引用元論文 1,602 件、この内訳の 11.9%イギリス: 引用元論文 725 件、この内訳の 5.4%ドイツ: 引用元論文 676 件、この内訳の 5%イタリア: 引用元論文 582 件、この内訳の 4.3%カナダ: 引用元論文 486 件、この内訳の 3.6%フランス: 引用元論文 485 件、この内訳の 3.6%日本: 引用元論文 444 件、この内訳の 3.3%スペイン: 引用元論文 403 件、この内訳の 3%オランダ: 引用元論文 286 件、この内訳の 2.1%韓国: 引用元論文 280 件、この内訳の 2.1%オーストラリア: 引用元論文 247 件、この内訳の 1.8%
0%31.4%その他 22.5%

分野

  • Medicine46.2%
  • Biochemistry, Genetics and Molecular Biology42.9%
  • Immunology and Microbiology4.5%
  • Neuroscience1.8%
  • Engineering0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • その他3.2%

トピック

  • Bladder and Urothelial Cancer Treatments6.8%
  • Cell death mechanisms and regulation3.3%
  • Urinary and Genital Oncology Studies2.8%
  • Epigenetics and DNA Methylation2.7%
  • Autophagy in Disease and Therapy2.1%
  • Cancer Cells and Metastasis2%
  • その他80.3%

共著者

全論文

検索で開く
  1. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Bullman, Kristen Leraas, Tara M. Lichtenberg, Catherine J. Wu, N. Schultz, Gad Getz, Matthew Meyerson, Gordon B. Mills, David J. McConkey, Rehan Akbani, Hikmat Al‐Ahmadie, Monique Albert, Iakovina Alexopoulou, Adrian Ally, Tatjana Antic, Manju Aron, Miruna Balasundaram, John M.S. Bartlett, Stephen B. Baylin, Allison Beaver, Joaquim Bellmunt, İnanç Birol, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Reanne Bowlby, Denise Brooks, Bradley M. Broom, Wiam Bshara, Susan Bullman, Eric Burks, Flavio Mavignier Cárcano, Rebecca Carlsen, Benilton S. Carvalho, André Lopes Carvalho, Eric Castle, Mauro A. A. Castro, Patricia Castro, James W.F. Catto, Vinicius S Chagas, Andrew D. Cherniack, David Chesla, Caleb Choo, Eric Chuah, Sudha Chudamani, Victoria K. Cortessis, Sandra Cottingham, Daniel Crain, Erin Curley, Bogdan Czerniak, Siamak Daneshmand, John A. Demchok, Noreen Dhalla, Hooman Djaladat, John Eckman, Sophie Egea, Jay Engel, Ina Felau, Martin L. Ferguson, Johanna Gardner, Julie M. Gastier‐Foster, Mark Gerken, Gad Getz, Ewan A. Gibb, Carmen Gomez‐Fernandez, Dmitry A. Gordenin, Guangwu Guo, Donna E. Hansel, Jodi Harr, Arndt Hartmann ほか 113 名 - Cell 2017 被引用: 2,535

  2. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mattias Aine, Hikmat Al-Ahmadie, Yves Allory, Joaquim Bellmunt, Isabelle Bernard-Pierrot, Peter C. Black, Mauro A.A. Castro, Keith Syson Chan, Woonyoung Choi, Bogdan Czerniak, Colin P. Dinney, Lars Dyrskjøt, Pontus Eriksson, Jacqueline Fontugne, Ewan A. Gibb, Clarice S. Groeneveld, Arndt Hartmann, Katherine A. Hoadley, Mattias Höglund, Aurélie Kamoun, Jordan Kardos, Jaegil Kim, William Y. Kim, David J. Kwiatkowski, Thierry Lebrét, Seth P. Lerner, Fredrik Liedberg, Núria Malats, David J. McConkey, Qianxing Mo, Thomas Powles, François Radvanyi, Francisco X. Real, Aurélien de Reyniès, A. Gordon Robertson, Arlene O. Siefker‐Radtke, Nanor Sirab, Roland Seiler, Gottfrid Sjödahl, Ann Taber, John N. Weinstein, Alexandre Zlotta - European Urology 2019 被引用: 1,360

  3. Comprehensive molecular characterization of urothelial bladder carcinoma Open

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Kwiatkowski, Andrew D. Cherniack, Weiguo Jian, Chandra Sekhar Pedamallu, Richard C. Gibbs, Seth P. Lerner, Kristian Cibulskis, Patricia Garrido Castro, Andrey Sivachenko, Chip Stewart, Michael S. Lawrence, Whitney D. McClenden, Margaret Morgan, Richard C. Gibbs, Scott L. Carter, Chad J. Creighton, Lawrence A. Donehower, Chad J. Creighton, C. Smith, Ami S. Bhatt, Trevor Pugh, Gordon Saksena, Lee Lichtenstein, Michael S. Lawrence, Carrie Sougnez, Kristian Cibulskis, Daniel DiCara, Petar Stojanov, Steven E. Schumacher, Doug Voet, Yingchun Liu, Jaegil Kim, Petar Stojanov, Doug Voet, Pei Lin, Hailei Zhang, Scott L. Carter, Scott Frazer, Michael S. Noble, Daniel DiCara, Lihua Zou, Bernard H. Bochner, Nils Gehlenborg, Ilana R. Garcia-Grossman, David I. Heiman, Juok Cho, Rameen Beroukhim, Dmitry A. Gordenin, David J. Kwiatkowski, Ami S. Bhatt, Andrey Sivachenko, Joonil Jung, Chip Stewart, Andrew D. Cherniack, Samuel S. Freeman, Eric Lander, Michael S. Noble, Tod D. Casasent, David J. Van Den Berg, David J. Kwiatkowski, Nikolaus Schultz, David J. Kwiatkowski, Jianjiong Gao, Anders Jacobsen, B. Arman Aksoy, Ami S. Bhatt, Petar Stojanov, Chandra Sekhar Pedamallu, Rameen Beroukhim, William Lee ほか 194 名 - Nature, Nat. 2014 被引用: 3,086

  4. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2014 被引用: 1,741

  5. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan L. Wright, Marc Dall’Era, Michiel S. van der Heijden, Peter C. Black - European Urology 2017 被引用: 792

  6. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes

    著者: , , , , , , , , , , - Applied immunohistochemistry & molecular morphology 2021 被引用: 153

  7. Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605

    著者: , , , , , , , , , , , , , , - European Urology 2023 被引用: 91

  8. Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2015 被引用: 541

  9. 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

    著者: , , , , , , , , , , , , , - Nature Reviews Urology 2021 被引用: 147

  10. Autophagy as a target for anticancer therapy

    著者: , , , - Nature Reviews Clinical Oncology 2011 被引用: 809

  11. Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

    著者: , , , , , , , , , - Cancer Research 2009 被引用: 862

  12. Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , - Science 2011 被引用: 595

  13. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

    著者: , , , , , , , , , - Nature Reviews Urology 2020 被引用: 195

  14. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Bullman, Kristen M. Leraas, Tara M. Lichtenberg, Catherine J. Wu, N. Schultz, Gad Getz, Matthew Meyerson, Gordon B. Mills, David J. McConkey, John N. Weinstein, David J. Kwiatkowski, Seth P. Lerner - Cell 2018 被引用: 587

  15. The consensus molecular classification of muscle-invasive bladder cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The Bladder Cancer Molecular Taxonomy Group - 2018 被引用: 152

  16. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 被引用: 123

  17. RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

    著者: , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 97

  18. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

    著者: , , , , , , , , , , , , , , , - EBioMedicine 2016 被引用: 342

  19. A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth R. Plimack, M.A. Hallman, Eric M. Horwitz, Essel Dulaimi Al-Saleem, David Y.T. Chen, Richard E. Greenberg, Alexander Kutikov, Gordon Guo, Timothy A. Masterson, Nabil Adra, Hristos Z. Kaimakliotis - European Urology 2023 被引用: 55

  20. Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 166

  21. Identification of Differential Tumor Subtypes of T1 Bladder Cancer

    著者: , , , , , , , , , , , , , , , , - European Urology 2020 被引用: 159

  22. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2019 被引用: 151

  23. Molecular profile of bladder cancer progression to clinically aggressive subtypes

    著者: , , , , , , , , - Nature Reviews Urology 2024 被引用: 78

  24. Enfortumab Vedotin–related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature

    著者: , , , , , , - European Urology Open Science 2023 被引用: 45